欧洲疫苗佐剂市场预测至 2030 年 – 区域分析 – 按佐剂类别（矿物盐佐剂、乳液佐剂、脂质体佐剂等）和类型（人用疫苗佐剂和兽用疫苗佐剂）
兽用疫苗佐剂的批准推动欧洲疫苗佐剂市场发展
为动物接种常见疾病疫苗仍然是全球范围内防止动物养殖中传染病造成经济和其他损失最成功的方法。兽用疫苗佐剂的监管批准正在增加，制造商越来越注重开发具有更高功效和稳定性的疫苗。Montanide 是已知的兽用疫苗佐剂之一。Montanide 佐剂系列基于三种核心技术——乳液、微乳液和聚合物。因此，兽用疫苗佐剂审批数量的激增加速了疫苗佐剂的整体市场增长。
欧洲疫苗佐剂市场概览
欧洲疫苗佐剂市场已细分为德国、英国、法国、意大利、西班牙和欧洲其他地区。一些顶级疫苗制造商在德国设有办事处。2022 年 12 月，赢创推出了一种名为 PhytoSquene 的植物基角鲨烯，以提高疫苗效力。它是一种适用于疫苗和其他药物应用的非动物衍生物。PhytoSquene 是市场上第一个已知的苋菜油衍生角鲨烯，用于非肠道用药的佐剂。赢创的这一最新创新旨在为市场提供可持续的非动物衍生解决方案。 2021 年，赢创推出了药用级和植物源胆固醇“PhytoChol”。
欧洲疫苗佐剂市场收入及 2030 年预测（百万美元）
欧洲疫苗佐剂市场细分
欧洲疫苗佐剂市场分为佐剂类别、类型和国家。
根据佐剂类别，欧洲疫苗佐剂市场细分为矿物盐佐剂、乳剂佐剂、脂质体佐剂等。矿物盐佐剂部分在 2022 年占据欧洲疫苗佐剂市场份额的最大份额。
按类型，欧洲疫苗佐剂市场分为人用疫苗佐剂和兽用疫苗佐剂。2022 年人用疫苗佐剂部分在欧洲疫苗佐剂市场中占有较大份额。 2022。
按国家/地区划分，欧洲疫苗佐剂市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。2022 年，德国占据了欧洲疫苗佐剂市场份额的主导地位。
Croda International Plc；CSL Ltd；Dynavax Technologies Corp；GSK Plc；InvivoGen SAS；Novavax Inc.；Phibro Animal Health Corp；Seppic SA；和 SPI Pharma Inc 是欧洲疫苗佐剂市场的一些领先公司。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Vaccine Adjuvants Market – Key Market Dynamics
4.1 Europe Vaccine Adjuvants Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic
4.2.2 Approvals of Veterinary Vaccine Adjuvants
4.3 Market Restraints
4.3.1 Product Recalls and Adverse Effects
4.4 Market Opportunities
4.4.1 Advancements in Biotechnology and Immunology
4.5 Future Trends
4.5.1 Technological Advancements
4.6 Impact of Drivers and Restraints:
5. Vaccine Adjuvants Market –Europe Market Analysis
5.1 Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
5.2 Europe Vaccine Adjuvants Market Forecast and Analysis
6. Europe Vaccine Adjuvants Market Analysis – by Adjuvant Class
6.1 Overview
6.2 Mineral Salt Adjuvant
6.2.1 Overview
6.2.2 Mineral Salt Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Emulsion Adjuvant
6.3.1 Overview
6.3.2 Emulsion Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liposome Adjuvant
6.4.1 Overview
6.4.2 Liposome Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Vaccine Adjuvants Market Analysis – by Type
7.1 Human Vaccine Adjuvant
7.1.1 Overview
7.1.2 Human Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Veterinary Vaccine Adjuvant
7.2.1 Overview
7.2.2 Veterinary Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Vaccine Adjuvants Market –Country Analysis
8.1 Europe
8.1.1 Europe Vaccine Adjuvants Market
8.1.1.1 Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Germany: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Germany: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.1.4 Germany: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.2 United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 United Kingdom: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.2.4 United Kingdom: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.3 France: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 France: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 France: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.3.4 France: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.4 Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Italy: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.4.4 Italy: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.5 Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.1 Overview
8.1.1.5.2 Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.3 Spain: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.5.4 Spain: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.6 Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.1 Overview
8.1.1.6.2 Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.3 Rest of Europe Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.6.4 Rest of Europe Vaccine Adjuvants Market Breakdown, by Type
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Global Vaccine Adjuvants Market
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10. Company Profiles
10.1 SPI Pharma Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 GSK Plc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 CSL Ltd
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Seppic SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Dynavax Technologies Corp
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 InvivoGen SAS
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Croda International Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Novavax Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Phibro Animal Health Corp
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
List of Tables
Table 1. Europe Vaccine Adjuvants Market Segmentation
Table 2. Europe Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)
Table 3. Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 4. Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 5. United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 6. United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 7. France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 8. France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 9. Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 10. Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 11. Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 12. Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 13. Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 14. Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies
List of Figures
Figure 1. Europe Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030
Figure 4. Europe Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)
Figure 5. Mineral Salt Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liposome Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)
Figure 10. Human Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Veterinary Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Vaccine Adjuvants Market – Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 13. Europe Vaccine Adjuvants Market (2022 and 2030)
Figure 14. Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 15. United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 16. France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 17. Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 19. Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 20. Growth Strategies in the Vaccine Adjuvants Market
- SPI Pharma Inc
- GSK Plc
- CSL Ltd
- Seppic SA
- Dynavax Technologies Corp
- InvivoGen SAS
- Croda International Plc
- Novavax Inc
- Phibro Animal Health Corp
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe vaccine adjuvants market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe vaccine adjuvants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe vaccine adjuvants market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.